IPO Boutique

Evogene Ltd. IPO Advisory

Share this IPO Profile:

Smart Search
Company begins with...
Company contains...

For IPO Boutique's "scale of 1 to 5" BUY rating on Evogene Ltd., and our comprehensive analysis, click "Buy Market Research".
Company
Symbol
Price Range
Issue Price
Open
Shares
Trade Date
Evogene Ltd.EVGN (trades on Tel Aviv SE) - Last trade $17.16 $0.00 $0.005 million11/21/2013
Credit Suisse, Deutsche Bank Securities
Co-Manager(s):
Oppenheimer, Piper Jaffray
Filing(s):

Filed 2013-09-23



About Evogene Ltd. (adapted from Evogene Ltd. prospectus):
They are a plant genomics company that uses a comprehensive and integrated technology infrastructure to enhance seed traits underlying crop performance and productivity through biotechnology and advanced breeding methods.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.



IPO Boutique aggregates information on public companies and private companies, such as "EVGN (trades on Tel Aviv SE)" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2024 IPO Boutique. All Rights Reserved